(Q72735559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Y Tsuboi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Ishikawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

G Fujisawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K Okada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

T Saito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

237-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1994.265

28 October 2019

exact match

0 references

cites work

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Antidiuretic hormone and renal function after water loading in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Metabolic clearance rate of arginine vasopressin in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Role of antidiuretic hormone in impaired urinary dilution associated with chronic bile-duct ligation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

4-Leucine-Oxytocin: Natriuretic, Diuretic, and Antivasopressin Polypeptide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

4-Phenylalanineoxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Effect of vasopressin antagonist on water excretion in inferior vena cava constriction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Discovery and therapeutic utility of vasopressin antagonists in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Chronic blockade of vasopressin receptors in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

[A simple and highly sensitive radioimmunoassay for 8-arginine vasopressin in human plasma using a reversed-phase C18 silica column]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Neurohypophyseal vasopressor principle: vasopressor hormone as well as antidiuretic hormone?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Vascular effects of arginine vasopressin during fluid deprivation in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.265

7 January 2021

Identifiers

DOI

10.1038/KI.1994.265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7933842%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference